Loading
Latest filing published 22 Jun 2026 for AEON Biopharma, Inc.. Read the official filing
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Jost Fischer in AEON Biopharma, Inc. In total, 5 filings cover trades dated from 21 July 2023 to 17 June 2026.
Every open-market trade on record is a purchase: 2 purchases worth €48k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 3 share grants.
Most recently, on 22 June 2026, the filings show a share grant in AEON Biopharma, Inc. The clock since the last published purchase (23 May 2025) now reads 513 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations